Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:
Sign Up
| Overall Assessment |
Comment |
Score |
| None |
BeiGene provides almost no transparency around climate-related lobbying. Its sustainability report contains only broad statements such as "BeiGene regularly engages with policymakers in support of our mission to provide high-quality, affordable medicines to patients," but it does not name any climate-related laws or regulations it seeks to influence, identify the governmental bodies it contacts, describe whether that engagement occurs through meetings, letters, trade associations, or other channels, or explain the specific policy outcomes it supports or opposes. As a result, readers are left without any concrete information on the policies lobbied, the mechanisms used, or the objectives pursued regarding climate policy.
|
0
|
| Overall Assessment |
Comment |
Score |
| None |
BeiGene’s disclosures provide no evidence of an internal governance framework for lobbying alignment. The company states that it “follows international governance guidelines and country-specific regulations and laws such as the Lobbying Disclosure Act in the U.S., to ensure proper interactions with government officials,” but this describes legal compliance rather than a policy or process for governing lobbying activities. We found no evidence of a policy to align lobbying with climate objectives, no description of a process to monitor or manage either direct lobbying or indirect lobbying through trade associations, and no named individual or committee overseeing lobbying alignment. While BeiGene “has assigned responsibility for climate related issues at the Board level through the Board’s participation in the Responsible Business & Sustainability (RB&S) Working Group,” that group’s remit focuses on climate risk assessment and emissions targets—having “reviewed and approved BeiGene’s climate risk assessment and strategy and … approved the first quantitative emissions Scope 1 and 2 reduction target”—with no mention of lobbying oversight. There is nothing in the disclosures to suggest any governance mechanism is specifically in place for lobbying or climate lobbying activities.
|
0
|